DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Amonafide is an investigational drug.
There have been 5 clinical trials for Amonafide. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2007.
The most common disease conditions in clinical trials are Leukemia, Myeloid, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Antisoma Research, Xanthus Pharmaceuticals, Inc., and Memorial Sloan Kettering Cancer Center.
Recent Clinical Trials for Amonafide
|A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)||Antisoma Research||Phase 2|
|Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study||Antisoma Research||Phase 3|
|Amonafide in Combination With Cytarabine in Secondary AML||Xanthus Pharmaceuticals, Inc.||Phase 2|